Connect
MJA
MJA

Medicinal cannabis in Australia: the missing links

Jennifer H Martin and Yvonne Bonomo
Med J Aust 2016; 205 (9): 425. || doi: 10.5694/mja16.00763
Published online: 7 November 2016

In their letter, Reece and Hulse point to a lack of high quality comparative efficacy data for cannabis use in many conditions, in distinction to the efficacy data required for therapeutic goods already registered for these same indications. As outlined in our article,1 there are a number of “missing links” that need to be considered before Australia is confident that safe and effective cannabis can be available to people in need. Moreover, recent publications provide summaries of the evidence for and against its safety and efficacy.2,3

  • Jennifer H Martin1,2
  • Yvonne Bonomo3

  • 1 University of Newcastle, Newcastle, NSW
  • 2 Hunter New England Local Health District, Newcastle, NSW
  • 3 St Vincent's Health, Melbourne, VIC


Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.